qPCR detection of Mycobacterium leprae in biopsies and slit skin smear of different leprosy clinical forms
- PMID: 27888674
- PMCID: PMC9425481
- DOI: 10.1016/j.bjid.2016.09.017
qPCR detection of Mycobacterium leprae in biopsies and slit skin smear of different leprosy clinical forms
Abstract
Leprosy, whose etiological agent is Mycobacterium leprae, is a chronic infectious disease that mainly affects the skin and peripheral nervous system. The diagnosis of leprosy is based on clinical evaluation, whereas histopathological analysis and bacilloscopy are complementary diagnostic tools. Quantitative PCR (qPCR), a current useful tool for diagnosis of infectious diseases, has been used to detect several pathogens including Mycobacterium leprae. The validation of this technique in a robust set of samples comprising the different clinical forms of leprosy is still necessary. Thus, in this study samples from 126 skin biopsies (collected from patients on all clinical forms and reactional states of leprosy) and 25 slit skin smear of leprosy patients were comparatively analyzed by qPCR (performed with primers for the RLEP region of M. leprae DNA) and routine bacilloscopy performed in histological sections or in slit skin smear. Considering clinical diagnostic as the gold standard, 84.9% of the leprosy patients were qPCR positive in skin biopsies, resulting in 84.92% sensitivity, with 84.92 and 61.22% positive (PPV) and negative (NPV) predictive values, respectively. Concerning bacilloscopy of histological sections (BI/H), the sensitivity was 80.15% and the PPV and NPV were 80.15 and 44.44%, respectively. The concordance between qPCR and BI/H was 87.30%. Regarding the slit skin smear, 84% of the samples tested positive in the qPCR. Additionally, qPCR showed 100% specificity, since all samples from different mycobacteria, from healthy individuals, and from other granulomatous diseases presented negative results. In conclusion, the qPCR technique for detection of M. leprae using RLEP primers proved to be specific and sensitive, and qPCR can be used as a complementary test to diagnose leprosy irrespective of the clinical form of disease.
Keywords: Bacilloscopy; Leprosy; Mycobacterium leprae; qPCR.
Copyright © 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. All rights reserved.
Figures
Similar articles
-
Evaluation of 16S rRNA qPCR for detection of Mycobacterium leprae DNA in nasal secretion and skin biopsy samples from multibacillary and paucibacillary leprosy cases.Pathog Glob Health. 2018 Mar;112(2):72-78. doi: 10.1080/20477724.2017.1415736. Epub 2017 Dec 26. Pathog Glob Health. 2018. PMID: 29279044 Free PMC article.
-
Development of a combined RLEP/16S rRNA (RT) qPCR assay for the detection of viable M. leprae from nasal swab samples.BMC Infect Dis. 2019 Aug 28;19(1):753. doi: 10.1186/s12879-019-4349-9. BMC Infect Dis. 2019. PMID: 31462296 Free PMC article.
-
qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.PLoS Negl Trop Dis. 2017 Jun 1;11(6):e0005506. doi: 10.1371/journal.pntd.0005506. eCollection 2017 Jun. PLoS Negl Trop Dis. 2017. PMID: 28570560 Free PMC article.
-
PCR-based techniques for leprosy diagnosis: from the laboratory to the clinic.PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2655. doi: 10.1371/journal.pntd.0002655. eCollection 2014 Apr. PLoS Negl Trop Dis. 2014. PMID: 24722358 Free PMC article. Review.
-
A case report and literature review: Mycobacterium leprae infection diagnosed by metagenomic next-generation sequencing of cerebrospinal fluid.BMC Infect Dis. 2024 Jul 3;24(1):666. doi: 10.1186/s12879-024-09473-z. BMC Infect Dis. 2024. PMID: 38961391 Free PMC article. Review.
Cited by
-
Validation of the performance of a point of care molecular test for leprosy: From a simplified DNA extraction protocol to a portable qPCR.PLoS Negl Trop Dis. 2024 Oct 7;18(10):e0012032. doi: 10.1371/journal.pntd.0012032. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39374296 Free PMC article.
-
qPCR detection of Mycobacterium leprae DNA in urine samples of leprosy patients using the Rlep gene target.Front Mol Biosci. 2024 Aug 13;11:1435679. doi: 10.3389/fmolb.2024.1435679. eCollection 2024. Front Mol Biosci. 2024. PMID: 39193223 Free PMC article.
-
MicroRNA biomarkers in leprosy: insights from the Northern Brazilian Amazon population and their implications in disease immune-physiopathology.Front Genet. 2024 Jan 25;15:1320161. doi: 10.3389/fgene.2024.1320161. eCollection 2024. Front Genet. 2024. PMID: 38343694 Free PMC article.
-
Challenges and advances in serological and molecular tests to aid leprosy diagnosis.Exp Biol Med (Maywood). 2023 Nov;248(22):2083-2094. doi: 10.1177/15353702231209422. Epub 2023 Dec 7. Exp Biol Med (Maywood). 2023. PMID: 38059475 Free PMC article. Review.
-
Specialized active leprosy search strategies in an endemic area of the Brazilian Amazon identifies a hypermutated Mycobacterium leprae strain causing primary drug resistance.Front Med (Lausanne). 2023 Sep 13;10:1243571. doi: 10.3389/fmed.2023.1243571. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37780551 Free PMC article.
References
-
- Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255–273. - PubMed
-
- Phetsuksiri B., Rudeeaneksin J., Supapkul P., Wachapong S., Mahotarn K., Brennan P.J. A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens. FEMS Immunol Med Microbiol. 2006;48:319–328. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical